Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease - Wikidata - wikimedia - TriplyDB

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

http://www.wikidata.org/entity/Q58603525

about

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

http://www.wikidata.org/entity/Q58603525

description

article publié dans la revue scientifique Scientific Reports

@fr

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@en

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@nl

type

label

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@en

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@nl

prefLabel

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@en

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@nl

P1433

Q58603525-FA812D77-A39D-4545-9DF4-60C5316257BA

P1476

Q58603525-343C9CA9-9225-4DB8-9186-99DA10201F63

P2093

Q58603525-2D54FD84-68E4-41F7-98B9-1F4BD1152C48

Q58603525-3373E194-DA84-4B7F-86F5-EC9C7F9F661D

Q58603525-39D72367-149B-4DEE-B010-DE220C833567

Q58603525-864EEBBC-C055-4941-B182-C333B683A91D

Q58603525-99AF27BB-00EB-4A47-98CF-B06D6EDD8A85

Q58603525-D6470472-9817-4604-B8E7-096C7C78F2AA

Q58603525-ED60B847-1E4A-44DE-BD7F-D20814CC9BCD

P2860

Q58603525-11AA237D-C6AA-4A23-93F6-BD74CCEAC4FF

Q58603525-19EDD152-AE98-49FA-9E76-C5D1D39E9BA7

Q58603525-1CC4A876-A193-4DA2-8021-1CF723CA29A3

Q58603525-1E29AE09-247E-469B-9EE7-2D708F15740C

Q58603525-245E0EAE-378B-457D-8CD0-8358B16A2E13

Q58603525-26EC0448-1DE8-4765-BB43-994CBF2345D7

Q58603525-2989B505-C815-42E6-BCA1-A4DE2D48C8A0

Q58603525-3FE19395-6989-40E9-A82D-41DEE41DEC59

Q58603525-4DBBEDEE-D30F-47B9-8BFA-A9E4F49F65CC

Q58603525-5B5DF6DA-F96C-4AC5-B8DC-915C84D1D8C3

P304

Q58603525-EF58B1F3-57F7-4AF0-89A9-638D8787ACF4

P31

Q58603525-A6BB8EDC-761B-4F04-B9C3-25CCC8DF4BBD

P356

Q58603525-5E6B2C6B-49CF-4599-BD38-1E7007AE8A2E

P407

Q58603525-9F66B6D5-3C15-4EB6-A666-BF091DD8FD3E

P433

Q58603525-210B961E-808D-4FCA-ABBC-F60CF3FF7192

P478

Q58603525-5D0FAE2D-F66E-401D-8307-A1083610A17A

P50

Q58603525-2F3AFDB6-E09B-4B1B-8652-5EF60C828674

Q58603525-31685CDF-7F49-4954-93A0-A77615D7D39F

Q58603525-98EDEECA-9A15-4972-AE1A-5AADECA1260E

Q58603525-E9B75EAB-8041-4E6B-BF6B-4A81F60F1246

P577

Q58603525-C7A934D9-DE63-4E06-A162-6A7796096331

P698

Q58603525-F6A83331-5821-42F7-96BD-713EAA4B1090

P921

Q58603525-F160FF74-2EFB-49BD-A0C2-711CA0199FBB

P932

Q58603525-F3BE8B58-1CAF-4E3F-9856-606AD073C79D

P356

S41598-018-33921-X

P1433

Scientific Reports

P1476

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

@en

P2093

Carol Dobson-Stone

http://www.w3.org/2001/XMLSchema#string

Deborah Hammond

http://www.w3.org/2001/XMLSchema#string

Gayathri Perera

http://www.w3.org/2001/XMLSchema#string

John B Kwok

http://www.w3.org/2001/XMLSchema#string

Nicole Mueller

http://www.w3.org/2001/XMLSchema#string

Russell Pickford

http://www.w3.org/2001/XMLSchema#string

Woojin Scott Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Glucocerebrosidase and Parkinson disease: Recent advances

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease

Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction

Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

Gaucher disease: insights from a rare Mendelian disorder.

P304

15446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-33921-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Glenda Halliday

Simon J.G. Lewis

Farzaneh Atashrazm

P577

2018-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30337601

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

6193988

http://www.w3.org/2001/XMLSchema#string